A study by scientists at the University of Texas Health Science Center at San Antonio provides one of the first models to study the progression of normal human pancreatic cells toward tumor cells.
Cedars-Sinai investigators who previously developed an imaging tool that used artificial intelligence to predict pancreatic cancer are now working to adapt that tool specifically for Black patients, who have disproportionately high rates of the disease.
